Genes & Diseases invites reviewers with expertise in: Human genetics & genomics Cancer biology Neurological, cardiovascular, and metabolic disorders Translational medicine and more Contact us: overseas@genesndiseases.com #Genetics #PeerReview #GenesAndDiseases

Explore the evolving understanding of acute coronary syndromes with Dr Frederick Welt! 📺 Women As One #CLIMB2025 presents Complex Cases! Watch Now 👉 https://t.co/FRmBi3Yq17 🔍 Advanced imaging techniques in ACS diagnosis 💡 Multiple mechanisms behind coronary events 🎯 How

Dr. @KalantriShreyas highlights practical guidance on navigating contract negotiations for early-career oncologists, shared by panelists during an #ASCO25 Trainee and Early Career Lounge session. Read more: https://t.co/iyDwUCdkiP #ASCOConnection

Register by November 3 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 9-12), directed by Carlos L. Arteaga and Virginia G. Kaklamani. Learn more: https://t.co/rTzNrTK2nW #SABCS25 @CarlosArteagaMD

This study from @CUHKofficial reveals how cNADK mutations control NADK activity and modulate cancer cell responses to chemotherapy, offering valuable molecular insights for developing targeted NADK-based cancer therapies. #OpenAccess: https://t.co/Rn7jNNOS6S

This review examines how #RibosomeBiogenesis, involving rRNA, ribosomal proteins, and biogenesis factors, shapes #LiverRegeneration, #HepatitisC, #NAFLD, and #LiverCancer, highlighting its potential as a therapeutic target. #OpenAccess: https://t.co/v6lNYF91b2

This review highlights TET1, a key enzyme in DNA demethylation, showing dual roles in cancer with both oncogenic and tumor suppressive properties, emphasizing the need for deeper mechanistic insights. #OpenAccess: https://t.co/e5Ptqc9Zu0

Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more: https://t.co/t4kC1jBzM1 #AACRIO26 @BhardwajLab

#WCLC25 recap: @JessicaJLinMD said the ECOG-ACRIN E4512 results won't change clinical practice after Dr. David Gerber reported no differences in OS or DFS. Read more:

Explore contemporary challenges in STEMI care with Dr Frederick Welt! 📺 Women As One #CLIMB2025 presents Complex Cases! Watch Now 👉 https://t.co/qjelTKe5UI 🔍 Evolution of AMI treatment approaches 💡 New perspectives on intervention timing 🎯 Future directions in acute

This study delves into the complex progression of neuroblastoma, from primary lesions to bone marrow metastases (BBM), and develops a predictive model for BBM status, laying a foundation for early diagnosis and personalized therapies. #OpenAccess: https://t.co/skiTcPbcMN

This review highlights the role of exosome/circulating lncRNAs in kidney diseases, exploring the disease mechanisms, their potential as biomarkers and therapeutic agents, and also offers new insights into lncRNA-based treatments. #OpenAccess: https://t.co/9jrHrePhlB

This study shows that XPR1 regulates MHC-I expression via autophagy in ovarian cancer & finds that combining targeted XPR1 with autophagy inhibitors effectively suppresses tumor growth, paving the way for new targeted therapeutics. #OpenAccess: https://t.co/HN28PpjhwK

Missed the live webinar on 'Optimizing Ablation with the Zero Exchange Workflow: Featuring a Live Case Recording'? You can now stream it on demand and explore the future of AFib ablation 👉 https://t.co/JoQbfQrd0u In this focused 30-minute session, Dr Stavros Mountantonakis and

Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more: https://t.co/kw73ikxotd #AACRras26

Hope. Innovation. Collaboration. In the latest #LungCancerConsidered, @NarjustFlorezMD chats with @nursesteagall & @AmandaNerstad about the 2025 Lung Cancer Hope Summit. Tune in now: https://t.co/N77FyhkSUA @LUNGevity

This study shows that Bcl6 maintains Treg cell stability and suppressive function in HNSCC, and suggests that inhibiting Bcl6 could disrupt Treg-driven immunosuppression, highlighting a promising therapeutic strategy for HNSCC treatment. #OpenAccess: https://t.co/TNFHuqreHU

New review from @CIEJZMU highlights the role of EMT in glioblastoma progression and therapy resistance, exploring challenges and strategies to improve treatment outcomes. #OpenAccess: https://t.co/w27fbjkUsQ

New review from @UChicagoMed highlights the diverse ways GPER contributes to endocrine resistance in HR+ breast cancer and explores it as a potential target to improve therapy outcomes. #OpenAccess: https://t.co/idsZBdyJmb

Deadline Extended:Submit an abstract by October 23 for the AACR Conference on Fusion-Positive Cancers (January 13-15; Philadelphia), chaired by Natasha J. Caplen, Mark E. Hatley, Ross A. Okimoto, and Kimberly Stegmaier. https://t.co/LWtu0WTg8O #AACRfusion26 @KStegmaier_DFCI

#AACR25 e-posters are available to meeting registrants for viewing through Friday, October 31. Learn more: https://t.co/f2UWhoE0sZ